Three New Two-Drug Regimens: Which Problem Does Each One Solve?
In this episode, Dr. Antonio E. Urbina, Medical Director for CEI’s HIV Primary Care and Prevention Center of Excellence, provides an overview of three new two-drug regimens: daily doravirine/islatravir, daily BIC/LEN, and once-weekly lenacapavir/islatravir. Related Content: CEI Line: 1-866-637-2342 ceitraining.org Hivguidelines.org https://viremic.org/episodes/case-30-problem-solving-with-new-arvs/transcript
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Conversations with CEI
Ditching the Script: Person-Centered Contraceptive Counseling
Anabolic Androgenic Steroids: Is “The Cycle” Addictive?
AIDS 2026 in Rio: What Came Out of the 26th International AIDS Conference
Updates on HSV Infection
Get summaries like this every morning.
Free AI-powered recaps of Conversations with CEI and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.